Extended Newborn Screening Panel Test
Test Price
1,200 AED✅ Home Collection Available
Extended Newborn Screening Panel – 1,200 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance on result interpretation by a DHA-licensed Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Extended Newborn Screening (Dried Blood Spot – DBS) utilizes tandem mass spectrometry (LC-MS/MS) and advanced immunoassays to detect over 50 inborn errors of metabolism from a single heel prick, ensuring early intervention in line with the UAE’s mandatory screening program. All testing is performed at DNA Labs UAE under strict ISO 9001:2015 quality management.
| Feature | DNA Labs UAE Extended Panel | Standard Public Screening (UAE Mandatory Panel) |
|---|---|---|
| Methodology | Tandem Mass Spectrometry (LC-MS/MS) + FEIA + Specialized Immunoassays | Basic Fluorometric / ELISA (limited panel) |
| Conditions Detected | 50+ inborn errors: metabolic, endocrine, hemoglobinopathies | ~10 disorders (mandatory UAE list only) |
| Diagnostic Sensitivity | 99.9% | ~95% |
| Turnaround Time | Next day (samples accepted Mon/Wed/Fri by 9 AM) | 5–7 working days |
| Sample Collection | Cold-chain home collection, heel prick DBS on LPL filter paper | Hospital visit only, ambient transport |
| Post-Test Guidance | Included telephonic consultation with specialist | Minimal / Self-referral |
Physician Insight & Safety Protocols
"As a medical geneticist, I understand the deep anxiety parents feel during newborn screening. This extended panel offers a comprehensive safety net, but an abnormal result must always be followed by confirmatory diagnostic testing and prompt specialist consultation. Early detection saves lives—please act quickly if a flag appears."
— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
⚠ Medication Safety Notice
Do not discontinue any prescribed medication for your baby without consulting your doctor.
Emergency Exclusion Criteria & Red Flags
⚠ Exclusion Criteria
- Infants with severe illness or extremely low birth weight (<1000 g) may require modified sampling protocols.
- If the neonate is on total parenteral nutrition (TPN) or antibiotics, draw the sample before administration or after clearance to avoid transient false elevations.
- Emergency Warning Signs: Lethargy, seizures, poor feeding, persistent vomiting, or hypotonia – proceed to the nearest ER immediately, regardless of screening results.
Patient FAQ & Clinical Guidance
1. What conditions does the extended newborn screening panel detect?
The panel detects over 50 inborn errors of metabolism, endocrine disorders, and hemoglobinopathies from a dried blood spot sample.
2. How is the sample collected for my newborn, and is it painful?
A quick heel prick collects a few drops of blood onto filter paper, causing minimal discomfort. The procedure is performed at your home by our trained phlebotomist.
3. What should I do if my baby’s screening result is abnormal?
An abnormal result indicates a possible metabolic disorder, warranting urgent confirmatory testing and immediate consultation with a medical geneticist. Our post-test telephonic guidance will assist you in taking the next steps.
UAE Regulatory & Data Privacy Adherence
Legal & Privacy Framework
All clinical data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Extended Newborn Screening Panel (Dried Blood Spot) |
| Price (AED) | 1,200 |
| Turnaround Time | Next day (samples accepted Monday, Wednesday, Friday by 9 AM) |
| Sample Type / Matrix | Dried Blood Spot (heel prick) |
| Methodology Used | Tandem Mass Spectrometry (LC-MS/MS) + Fluoroenzyme Immunoassay (FEIA) |
| ICD-10-CM Code | Z13.2 |
| LOINC Code | 73793-4 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
⚕️ Medical Disclaimer
This test information is for educational purposes only and does not constitute medical advice. Results should be interpreted by a qualified healthcare professional. Always consult with a DHA-licensed physician for diagnosis and treatment decisions.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians